ResearcherNanjing Drum Tower HospitalActive in the last 2 years
Yixuan Zhang
Matched on ORCID iD 0000-0001-9781-6281; OpenAlex author ID A5100396612. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2023: 1 paper · 2024: 1 paper · 2025: 3 papers
Papers 5
- Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013269↗
- Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progressio… First author DOI 10.1177/17448069251371549↗
- Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12951-025-03795-z↗
- High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial… First author DOI 10.1016/j.bios.2024.116411↗
- Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Co-author DOI 10.1038/s41467-023-40727-7↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shu Zhang · 4 shared papers, 2023–2025 · strength 0.76
- Paper Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcino… DOI 10.1177/17448069251371549↗
- Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
- Paper Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. DOI 10.1136/jitc-2025-013269↗
- Shijin Xu · 2 shared papers, 2025 · strength 0.40
- Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
- Paper Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. DOI 10.1136/jitc-2025-013269↗
- Ying Lv · 2 shared papers, 2025 · strength 0.40
- Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
- Paper Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. DOI 10.1136/jitc-2025-013269↗
- Ying Lv · 2 shared papers, 2023–2024 · strength 0.34
- Paper High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative p… DOI 10.1016/j.bios.2024.116411↗
- Paper Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver me… DOI 10.1038/s41467-023-40727-7↗
- Shenquan Cai · 1 shared paper, 2025 · strength 0.22
- Gao-jian Tao · 1 shared paper, 2025 · strength 0.22
- Jiajun Zhang · 1 shared paper, 2025 · strength 0.21
- Ziwei Zhang · 1 shared paper, 2025 · strength 0.21
- Li Lin · 1 shared paper, 2025 · strength 0.21
- Song Zhang · 1 shared paper, 2024 · strength 0.20
- Zhixian Zhu · 1 shared paper, 2024 · strength 0.20
- Nan Xiang · 1 shared paper, 2024 · strength 0.20
- Lei Wang · 1 shared paper, 2025 · strength 0.19
- Jiatong Tang · 1 shared paper, 2025 · strength 0.19
- Xiaoping Zou · 1 shared paper, 2025 · strength 0.19
- Qi Li · 1 shared paper, 2025 · strength 0.19
- Lei Wang · 1 shared paper, 2023 · strength 0.14
- Hao Wu · 1 shared paper, 2023 · strength 0.14
- Dongming Zhu · 1 shared paper, 2023 · strength 0.14
- Chao Yan · 1 shared paper, 2023 · strength 0.14
- Shanshan Shen · 1 shared paper, 2023 · strength 0.14
- Xiaoping Zou · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.